| |
| |
|
| Insider
Information: |
Russell Angus C. |
| Relationship: |
Director |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
129,798 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$229,796 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
129,798 |
|
|
| Total
Value |
$229,796 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 39.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2011-10-31 |
0 |
Premium* |
|
|
Questcor Pharmaceuticals Inc |
QCOR |
Director |
2014-08-14 |
0 |
2013-06-08 |
0 |
Premium* |
|
|
Mallinckrodt plc |
MNK |
Director |
2020-11-12 |
0 |
2014-08-14 |
0 |
Premium* |
|
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director |
2021-06-29 |
87,500 |
|
0 |
Premium* |
|
|
Therapeuticsmd Inc |
TXMD |
Director |
2022-08-18 |
5,792 |
2015-05-12 |
0 |
Premium* |
|
|
Revance Therapeutics, Inc. |
RVNC |
Director |
2023-05-03 |
36,506 |
2017-05-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2023-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,534 |
36,506 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2022-08-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,984 |
5,792 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2021-12-13 |
4 |
B |
$15.74 |
$100,741 |
D/D |
6,400 |
26,913 |
2.39 |
% |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2021-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,864 |
190,364 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • – |
2021-06-29 |
4 |
OE |
$2.20 |
$54,384 |
D/D |
24,720 |
92,220 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • – |
2021-06-29 |
4 |
S |
$2.97 |
$14,018 |
D/D |
(4,720) |
87,500 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2021-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,013 |
20,513 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2020-11-12 |
4 |
S |
$0.13 |
$6,665 |
D/D |
(51,789) |
0 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2020-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
16,500 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2020-05-13 |
4 |
D |
$2.96 |
$35,644 |
D/D |
(12,042) |
51,789 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2019-08-23 |
4 |
B |
$2.77 |
$27,700 |
D/D |
10,000 |
93,500 |
2.39 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2019-08-15 |
4 |
B |
$2.99 |
$29,900 |
D/D |
10,000 |
83,500 |
2.39 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2019-08-14 |
4 |
B |
$2.76 |
$69,000 |
D/D |
25,000 |
73,500 |
2.39 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
26,759 |
63,831 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2019-05-15 |
4 |
D |
$15.21 |
$178,930 |
D/D |
(11,764) |
37,072 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
10,500 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
26,141 |
48,836 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
6,000 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2018-03-01 |
4 |
D |
$15.68 |
$40,392 |
D/D |
(2,576) |
22,695 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2017-10-01 |
4 |
D |
$37.37 |
$17,788 |
D/D |
(476) |
25,271 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2016-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,057 |
22,310 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2016-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,037 |
21,253 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2016-03-16 |
4 |
D |
$55.69 |
$25,506 |
D/D |
(458) |
20,216 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2016-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,041 |
20,674 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
